Adding new vaccines to the routine immunization program: the role of NITAGs

China
3 October 2016

On 21 September, 2016 a workshop was held in Beijing, China to discuss the process of adding new vaccines to the routine immunization program through a strong national immunization technical advisory group (NITAG).

Flag_of_the_People's_Republic_of_China.svg.png

China’s EPI system was established in 1978 provides government-purchases vaccines at no charge to parents of children up to 14 years of age.  Initially, the program included vaccines for 6 infectious diseases (tuberculosis, diphtheria, tetanus, pertussis, polio, and measles).  The schedule has been expanded three times: in 2002 to include hepatitis B vaccine, in 2007 to include rubella, mumps, hepatitis A, meningococcal, and Japanese encephalitis vaccines, and in 2016 when IPV was added.  Six vaccines that are recommended by WHO for use in all immunization programs - Hib, pneumococcal conjugate, rotavirus, varicella, human papillomavirus, and influenza) - are not included in China’s EPI system and as such the government is seeking to strengthen its decision making processes so it can effectively consider introduction of these vaccines.
The workshop was co-hosted by the World Health Organization (WHO) China Representative Office, the Chinese Preventive Medicine Association (CPMA), and the Chinese Center for Disease Control and Prevention (China CDC). Participants included EPI leadership from the National Health and Family Planning Commission (Ministry of Health), members of China’s NITAG, provincial CDC EPI leadership, UNICEF, and CPMA public health leadership fellows.
The objectives of the meeting were to 
(1) Share knowledge and best practices for new vaccine introduction and NITAG strengthening from global, regional, and national perspectives;
(2) Make recommendations to improve the ability of China’s EPI system to add new vaccines to the program through a strong NITAG.
Representatives from NITAGs in China, Germany, Malaysia, the United Kingdom, and the United States shared their experiences, and a fruitful discussion was held. Partners committed to supporting China as it looks to strengthening its evidence-based immunization decision making process. 

 

Related News & Events

  • China

    A brand new way of training NITAG : the exemple of China

    05.02.2018

    A unique training for NITAG was organized in Beijing on December 12-14 2017. For the first time, the training gathered together NITAG chair and members but also the working group leaders, ex-officio members and liaison members as well as NITAG from other countries as facilitators.
     

    Read more
  • China

    Chinese EPI Leadership Conducts NITAG Study Tour of Canada and the United States

    10.11.2016

    Top EPI leaders in China’s National Health and Family Planning Commission (NHFPC) travelled to Ottawa and Atlanta to discuss mechanisms for including new vaccines into existing immunization programs by use of a strong National Immunization Technical Advisory Group – in this case, Canada’s National Advisory Committee on Immunization (NACI) and the United States’ Advisory Committee on Immunization Practices (ACIP).  

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more